Dr. Dowell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-8600Fax+1 214-645-2615
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1997 - 2000
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1993 - 1996
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1993
Certifications & Licensure
- TX State Medical License 1994 - 2025
- TN State Medical License 1999 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma Start of enrollment: 2006 Jun 01
- Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma Start of enrollment: 2006 Feb 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Corneal Transplant Rejection Following Durvalumab Therapy in a Patient With NSCLC: A Case Report.Luise Froessl, Puja Panwar, Subir Bhatia, Jonathan Dowell
Journal of Immunotherapy. 2025-01-01 - Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brie...Yuanyuan Zhang, Puneeth Iyengar, Steven Montalvo, Kenneth D Westover, Sawsan Rashdan
International Journal of Radiation Oncology, Biology, Physics. 2025-01-01 - Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans withG12C-Mutated NSCLC.Katherine I Zhou, Chenyu Lin, Chin-Lin Tseng, Nithya Ramnath, Jonathan E Dowell
JTO Clinical and Research Reports. 2024-05-01
Journal Articles
- Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published CasesDavid E Gerber, Jonathan E Dowell, Clinical Lung Cancer
Authored Content
- Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published CasesNovember 2018
Press Mentions
- Medical Student Training to Tackle Health Disparities with Language Skills ProgramJuly 15th, 2021
- Double-Drug Strategy Blocks Escape Route for Most Lung CancersApril 5th, 2018
- Texas Researchers Summarize Promising Research on New Mesothelioma Drug, According to Surviving MesotheliomaMay 2nd, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: